TY  - JOUR 
AU  - López-Muñoz, F.
AU  - Álamo González, C
PY  - 2011
SN  - 0362-5664
SN  - 1537-162X
UR  - http://hdl.handle.net/20.500.12020/728
AB  - Psychopharmacology of schizophrenia has remained static for many years because the mechanisms explored have been basically monoaminergics, primarily focused toward the modification of dopaminergic function and, later on, serotonergic. In fact, most of...
LA  - en
PB  - Wolters Kluver
TI  - Neurobiological background for the development of new drugs in schizophrenia
DO  - 10.1097/WNF.0b013e318215c2f7
T2  - Clinical Neuropharmacology
M2  - 111
KW  - Farmacologia
KW  - Neurologia
KW  - Neurociencia
KW  - Psicofarmacologia
VL  - 34
ER  -